2024, Clinical Pharmacology and Communication

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2024

Clinical Pharmacology

Communication

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

Putting Patients First Blog

SEPTEMBER 26, 2024

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials (PDF) September 26, 2024 The Honorable Robert M. Food and Drug Administration 5630 Fishers Lane Rockville, MD 20852 RE: Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies [Docket No. 8 Scott, P.,

Communication

Communication Clinical Pharmacology Documentation Drug Development

FDA drug dosage optimisation guidelines signal clinical trial reform

Pharmaceutical Technology

FEBRUARY 17, 2023

In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov. If the new clinical study finds that a lower drug dose can achieve similar efficacy, the hope is that this could result in fewer side effects for patients.

Dosage

Dosage Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies

Pharmacist Digest

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

FDA drug dosage optimisation guidelines signal clinical trial reform

Stay Connected